Showing posts from tagged with: Pathway Genomics Blog

Using Genetic Information for Healthy Lifestyle Management

Posted on 10/02/2014 in Blog Post

medcan graphic
SAN DIEGO, CAOctober 2. 2014 – Genetic testing provides the opportunity to gain all sorts of insight--from the potential to diagnose rare diseases, to providing targeted therapies, to prevention. Although we have historically focused on the use of genetic testing for diagnosis, less attention has been given to genetic testing’s clinical use in preventing disease and managing health. In the US, only 2% of the population has ever undergone genetic testing. However many studies show that the majority of patients and physicians believe that genetic testing is on the rise and that a significantly higher portion of the population could benefit from genetic testing to help identify risk for and even diagnose preventable conditions.  

Pathway Genomics Launches BreastTrue NGS High Risk Breast Cancer Panel with PALB2

Posted on 09/10/2014 in News, Press Releases

breasttrue-header
SAN DIEGO, CASeptember 10. 2014 – Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, today announced it has launched BreastTrueTM High Risk Panel, a next-generation sequencing test with deletion/duplication analysis to detect mutations in seven high-risk breast cancer susceptibility genes, including BRCA1, BRCA2 and PALB2.